| Dr Christine A Cheng, MD | |
|
415 Medical Dr, Suite D102, Bountiful, UT 84010-4946 | |
| (801) 298-9774 | |
| Not Available |
| Full Name | Dr Christine A Cheng |
|---|---|
| Gender | Female |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 38 Years |
| Location | 415 Medical Dr, Bountiful, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306848338 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 95-294457-1205 (Utah) | Primary |
| Entity Name | Ihc Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629260880 PECOS PAC ID: 1850209420 Enrollment ID: O20031105000079 |
News Archive
The current COVID-19 pandemic is having a huge impact on people across the globe and in these unprecedented times we consider it more important than ever that we continue to support the publication of relevant and timely research.
BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced its investment in a newly-formed ophthalmic company that has licensed-in a world-wide drug-delivery platform from the Hebrew University, Israel, that has the potential to enable more efficient and safer delivery of eye drops.
An ophthalmologist at Washington University School of Medicine in St. Louis is implanting radioactive discs in the eyes of children with a rare cancer in an attempt to save their vision and their eyes.
An international project lead by the Molecular and Cell Biology Institute of Porto University with the participation of researchers from IMIM (Hospital del Mar Medical Research Institute) has, for the first time ever, deciphered the mechanism by which a substance called anophelin binds to an enzyme (thrombin) involved in the process of blood coagulation.
› Verified 9 days ago
| Entity Name | Christine A. Cheng Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073151536 PECOS PAC ID: 9830512367 Enrollment ID: O20200630003443 |
News Archive
The current COVID-19 pandemic is having a huge impact on people across the globe and in these unprecedented times we consider it more important than ever that we continue to support the publication of relevant and timely research.
BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced its investment in a newly-formed ophthalmic company that has licensed-in a world-wide drug-delivery platform from the Hebrew University, Israel, that has the potential to enable more efficient and safer delivery of eye drops.
An ophthalmologist at Washington University School of Medicine in St. Louis is implanting radioactive discs in the eyes of children with a rare cancer in an attempt to save their vision and their eyes.
An international project lead by the Molecular and Cell Biology Institute of Porto University with the participation of researchers from IMIM (Hospital del Mar Medical Research Institute) has, for the first time ever, deciphered the mechanism by which a substance called anophelin binds to an enzyme (thrombin) involved in the process of blood coagulation.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christine A Cheng, MD 415 Medical Dr, Ste D102, Bountiful, UT 84010-8906 Ph: (801) 593-9223 | Dr Christine A Cheng, MD 415 Medical Dr, Suite D102, Bountiful, UT 84010-4946 Ph: (801) 298-9774 |
News Archive
The current COVID-19 pandemic is having a huge impact on people across the globe and in these unprecedented times we consider it more important than ever that we continue to support the publication of relevant and timely research.
BioLight Life Sciences Investments Ltd., a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced its investment in a newly-formed ophthalmic company that has licensed-in a world-wide drug-delivery platform from the Hebrew University, Israel, that has the potential to enable more efficient and safer delivery of eye drops.
An ophthalmologist at Washington University School of Medicine in St. Louis is implanting radioactive discs in the eyes of children with a rare cancer in an attempt to save their vision and their eyes.
An international project lead by the Molecular and Cell Biology Institute of Porto University with the participation of researchers from IMIM (Hospital del Mar Medical Research Institute) has, for the first time ever, deciphered the mechanism by which a substance called anophelin binds to an enzyme (thrombin) involved in the process of blood coagulation.
› Verified 9 days ago
Joseph Gregory Kjar, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 415 Medical Dr, Ste #b-200, Bountiful, UT 84010 Phone: 801-295-9105 Fax: 801-295-9264 | |
Dr. Daniel Shane Sellers, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 620 Medical Dr, Suite 310, Bountiful, UT 84010 Phone: 801-295-6554 |